Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy
Status:
Terminated
Trial end date:
2019-04-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of long-term addition of SmofKabiven®
E to normal oral nutrition after routine dietary counseling as compared to standard of care
nutrition in which oral nutrition is the primary nutritional support. It takes place in lung
cancer patients under chemo- and/or immunotherapy. Efficacy will be determined primarily by
calculating the change of patient's body weight from before start of study treatment to end
of treatment, and comparing this change between both treatment groups.